News & Updates

Follow-up monitoring of the carotid artery with contrast-enhanced ultrasonography (CEUS) identifies response or relapse in most patients with Takayasu arteritis (TAK), reports a study.

Risk stratification for myocardial infarction and death in patients with suspected obstructive coronary artery disease (CAD) may be improved by the addition of coronary artery calcium score (CACS) to classical risk factors in simple clinical likelihood (CL) models compared with the basic pretest probability (PTP) model, suggests a recent study.

Structural valve dysfunction (SVD) has occurred in nearly one in four young women with bioprosthetic heart valves (BPVs) at the first antenatal visit, and this may have harmful effects in pregnancy outcomes, reports a study. Specifically, SVD of left-sided BPVs is associated with high rates of adverse events (AEs).

Staying true to its long history of committed partnership with healthcare professionals on Continuing Medical Education (CME) and product innovation, ZP Therapeutics made a grand return to face-to-face CME events in celebration of ZP Therapeutics’ illustrious 100-year history as a leading healthcare industry partner. The ZPT Exposition of Experts in Improving Patient Outcomes 2022, themed “Zvolution -Making Healthcare More Accessible”, was held at the Conrad Hotel in Pasay City last 23–24 September 2022 and featured a panel of top-notch speakers whose talks covered a broad range of topics from digital health solutions to Gastroenterology, bone health, immunity as well as critical care in diabetes, and Cardiology. 

Exposure to elevated concentrations of small particulate matter appears to confer an immediate increase in the risk of out-of-hospital cardiac arrest (OHCA), which subsequently decreases over a few days after exposure, according to data from the Pan-Asian Resuscitation Outcomes Study (PAROS) conducted in Singapore.

The use of an implantable loop recorder (ILR) device can help reduce stroke incidence in individuals without cardiovascular diseases (CVD), according to a recent study. However, screening with such device appears to have limited benefit in those with CVDs.

Prophylactic use of methylprednisolone does not appear to improve outcomes in infants undergoing cardiopulmonary bypass, even posing an increased risk of hyperglycaemia that requires insulin treatment, according to a study.